General Psychiatry - Articles | CARLAT PUBLISHING

RESEARCH UPDATE

Comparing Side Effect Sizes With a Free New Tool

June 12, 2025

Kamron Fariba, MD. Dr. Fariba has no financial relationships with companies related to this material.

A new digital tool helps clinicians compare psychiatric medications based on side effect profiles—streamlining complex decisions with data from dozens of major studies and treatment guidelines.

RESEARCH UPDATE

Repurposing Antinausea Medications for OCD

June 12, 2025

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial conflicts with companies related to this material.

CLINICAL UPDATE

Liraglutide: A Generic Option for Weight Gain

June 12, 2025

Edmund S. Higgins, MD

Edmund S. Higgins, MD. Affiliate Associate Professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina.

Dr. Higgins reports stock ownership in Bristol-Myers-Squibb and Johnson & Johnson. Dr. Aiken has reviewed this educational activity and determined that there is no commercial bias as a result of this financial relationship.

Liraglutide offers an affordable GLP-1 option for managing antipsychotic weight gain.

CLINICAL UPDATE

Generic Lurasidone Shifts the Balance in Bipolar Depression

June 12, 2025

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Lurasidone was heralded as a game changer when it first gained FDA approval for bipolar depression in 2013. In 2023, this article covers what that means for patients with bipolar disorder and schizophrenia who can now afford its $10–$20/month cost.

EXPERT Q&A

A Clozapine Primer

June 12, 2025

Jonathan G. Leung, PharmD, RPh, Clinical pharmacist specialist, Mayo Clinic, Rochester, MN. Associate Professor of Pharmacy and Associate Professor of Psychiatry, Mayo Clinic, College of Medicine and Science.

Dr. Leung has no financial relationships with companies related to this material.

There are over 20 antipsychotics, so which one do you start with? Dr. Leung, who helped start a clozapine clinic gives us a primer on Clozapine.

RESEARCH UPDATE

SSRI-Induced Sexual Dysfunction: Are Weekend Holidays Effective?

June 12, 2025

Dee Rapposelli

Dee Rapposelli. Ms. Rapposelli has no financial relationships with companies related to this material.

Two recent studies suggest that taking short, scheduled breaks from SSRIs may help reduce sexual side effects in both men and women.

Cobenfy: A New Antipsychotic

June 12, 2025

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Last fall, the FDA approved xanomeline/trospium (Cobenfy) for adults with schizophrenia. Here's a closer look at this treatment.